Australia aims to be the first nation to eliminate a cancer – can it achieve this milestone?

Australia wants to become the first – Chrissy Walters still recalls the day her world turned upside down. Six months after giving birth to her first child, after years of battling infertility, she was told her daughter would likely outlive her. The diagnosis came after a major bleed during a routine home visit in Toowoomba, a small town two hours inland from Brisbane. Following multiple hospital visits, doctor consultations, and biopsies, the then 39-year-old was informed she had advanced cervical cancer. “I just said to [my husband] Neil… there must have been a mistake,” she remembers. Despite over a decade of treatment, the disease has progressed, and her doctors now predict a terminal outcome. “I would never wish this on my worst enemy,” Walters says, reflecting on the emotional toll of the illness. Her 12-year-old daughter has grown up in the shadow of cancer, with the family discussing mortality as early as when she was three.

The Fight Against Cervical Cancer

Cervical cancer, though often asymptomatic, is a leading cause of death among women globally. It is the fourth most common cancer in women, yet it remains one of the few that can be prevented through vaccination. Australia has emerged as a pioneer in this fight, leveraging a national immunisation programme to curb the disease. The country’s strategy includes vaccinating adolescents, improving screening methods, and fostering public awareness. These efforts have positioned Australia to potentially become the first nation to eliminate cervical cancer as a public health issue.

“It feels like everyone has a mother or a sister or a grandmother that’s been impacted by cervical cancer,” says Professor Karen Canfell, a leading epidemiologist. “But now, we’re seeing a shift toward a future where that’s no longer the case.”

Australia’s journey began in 2006 with a breakthrough in Queensland. Australian scientists, after decades of research, developed the Gardasil vaccine, which targets the human papillomavirus (HPV) – a key contributor to cervical cancer. The vaccine was approved by the country’s medicines regulator, and the following year, Australia launched the first global national programme for HPV immunisation. This initiative sparked optimism among health experts, who saw a clear path to reducing the disease’s prevalence. Models created by Canfell and the World Health Organisation (WHO) projected that elimination could be achieved within a generation.

The programme’s success hinges on two pillars: vaccination and early detection. Initially, the focus was on girls, but in 2013, the plan expanded to include boys. This decision, based on evidence that men can also carry and transmit the virus, has broadened its impact. Australia’s HPV-based cervical screening programme, introduced in 2017, further enhanced its approach. Replacing the traditional pap smear with a more sensitive test, this method requires screening every five years. The shift also allowed women to collect their own samples, a change the government hailed as a “game-changer” for those uncomfortable with pelvic exams or facing access barriers.

A New Era of Prevention

The transition to HPV-based screening marked a significant step in Australia’s public health strategy. By detecting the virus itself rather than its cellular changes, the programme offers earlier and more accurate identification of risk. This precision has reduced the burden on healthcare systems, allowing for targeted interventions. The WHO’s goal of cervical cancer elimination by 2040 has been accelerated by Australia’s proactive measures, which are now serving as a model for other nations.

Statistical progress underscores Australia’s achievements. Since 1982, incidence and mortality rates for cervical cancer have halved, according to records. The most recent data from 2021 reveals a historic milestone: no new cases were diagnosed in women under 25. While this doesn’t mean the disease is eradicated for all age groups, it signals a transformative shift in prevention. “It’s not all women of all ages yet,” Canfell acknowledges, “but the concept of elimination is becoming a reality.”

Current figures show Australia has approximately 6.3 new cervical cancer cases per 100,000 women. This rate, while still present, is a fraction of what it was decades ago. The high vaccination rate among girls under 15 – just over 80% – and the 85% screening participation in critical age groups contribute to this decline. These metrics suggest the programme is on track to meet its 2035 target, with some experts predicting it may reach the goal even sooner.

Challenges and Opportunities

Despite its progress, Australia’s mission is far from complete. Cervical cancer remains a concern for women over 65, who may not have been vaccinated as adolescents. Additionally, disparities in access to healthcare could affect outcomes for rural and socioeconomically disadvantaged communities. However, the nation’s robust infrastructure and commitment to innovation have mitigated many of these challenges. The combination of mass immunisation, advanced screening, and public education has created a comprehensive approach.

Canfell highlights the importance of sustained investment. “Public health innovations in Australia have set a precedent,” she says, “but elimination requires continuous effort.” The country’s early adoption of HPV vaccines and screening technologies has given it a competitive edge, allowing it to race other nations toward the first-ever cancer elimination. This achievement could redefine how the world tackles preventable diseases, offering a blueprint for global health.

For families like Walters’, the progress is tangible. Her daughter, now 12, has grown up in a world where cervical cancer is no longer an inevitability. The vaccine, once a medical breakthrough, is now a routine part of Australia’s youth immunisation schedule. Yet, the journey to full eradication is ongoing, with new cases still emerging. The ultimate goal is to reach a point where cervical cancer is a rare occurrence, impacting only a few individuals annually. If achieved, Australia could mark a turning point in cancer prevention, proving that what once seemed impossible is now within reach.

As the nation moves forward, the success of its programme will depend on maintaining high vaccination coverage and ensuring equitable access to screening. The road to elimination is paved with scientific innovation, but it also requires societal commitment. With each generation, the risk of cervical cancer diminishes, offering hope that one day, the disease may no longer define a woman’s life. For Chrissy Walters, the fight continues, but she now faces it with the knowledge that her daughter’s future is brighter than her own.